SPC5001: Clinical Trials

1 trial of SPC5001, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow SPC5001: new trials by email Literature Review of SPC5001 trials Research Report on SPC5001

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multiple Ascending Dose Study of SPC5001 in Treatment of Healthy Subjects and Subjects With FH
SPC5001, Saline 0.9% - Hypercholesterolemia
Phase 1TerminatedSantaris Pharma A/S242011-05-012011-11-22

Conditions studied

Hypercholesterolemia (1)  ·  Hyperlipidemias (1)

Sponsors

Santaris Pharma A/S (1)

Countries

Netherlands (1)

Top investigators

Koos Burggraaf, MD PhD (1)

Results publications

PMID 26261033